LymphaTouch Oy (LymphaTouch) was founded in 2005 out of a desire to help patients with lymphatic and circulatory problems by using innovative vacuum technology. The company provides easy-to-use and effective solutions for patients recovering from e.g. breast cancer treatments, sport injuries, post surgery swelling or scars.
LymphaTouch is certified as an ISO13485 compliant medical device manufacturer and has received CE and US FDA medical device approval.
LymphaTouch's current owners include Innovestor, one of Finland's largest private equity firms, and a number of well-known angel investors. LymphaTouch's Board is chaired by Leena Niemistö, MD, specialist in physiatry and government professional. The company's key people form a diverse and experienced team, combining many years of experience in the health technology sector and its sub-sectors.
In 2023, LymphaTouch signed a major technology collaboration agreement with Mego Afek of Israel. This partnership agreement opens the door to a whole new market and creates unprecedented opportunities in the company's history.
Mego Afek's strong network and international presence provide LymphaTouch with a unique opportunity to expand globally and reach healthcare professionals and patients in new regions. By combining resources and expertise, LymphaTouch and Mego Afek will create synergies that will strengthen both companies' position as pioneers in health technology.
This technology partnership agreement not only expands LymphaTouch's business opportunities, but also supports the company's mission to bring relief and improve the quality of life for patients worldwide.